17,658
Total Claims
$1.1M
Drug Cost
1,933
Beneficiaries
$578
Cost/Patient
Peer Comparison vs. 13,194 Neurology providers
-86%
Cost per patient vs peers
$578 vs $4,034 avg
-40%
Brand preference vs peers
5.7% vs 9.4% avg
Brand vs Generic
94% generic
Brand: 998 claims · $714K
Generic: 16,547 claims · $400K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Glatiramer Acetate | 19 | $183K |
| Memantine Hcl | 5,014 | $111K |
| Rimegepant Sulfate | 60 | $99K |
| Eslicarbazepine Acetate | 46 | $86K |
| Memantine Hcl | 244 | $50K |
| Dextromethorphan Hbr/Quinidine | 30 | $43K |
| Ubrogepant | 26 | $40K |
| Lacosamide | 149 | $34K |
| Lacosamide | 25 | $29K |
| Lamotrigine | 15 | $28K |
| Memantine Hcl/Donepezil Hcl | 44 | $26K |
| Rivastigmine | 109 | $25K |
| Donepezil Hcl | 52 | $25K |
| Donepezil Hcl | 2,613 | $23K |
| Levetiracetam | 577 | $22K |
Prescribing Profile
49
Unique Drugs
Patient Profile
74
Avg Age
65%
Female
2.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About